In the article titled “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models” [1], there was a typographical error in Figure 4(b) where the label of the statistical difference symbol should be corrected as follows:. Here, EPCAM is linked to colorectal cancer.